These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15066289)

  • 1. The PSA conundrum.
    Vikram B
    Radiother Oncol; 2004 Apr; 71(1):1-2. PubMed ID: 15066289
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-line therapy after radical prostatectomy failure: for whom? When? How?
    Aus G
    Eur Urol; 2007 May; 51(5):1155-7; discussion 1157-8. PubMed ID: 17307285
    [No Abstract]   [Full Text] [Related]  

  • 3. [PSA follow-up after radical prostatectomy].
    Egawa S; Baba S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():284-8. PubMed ID: 12599586
    [No Abstract]   [Full Text] [Related]  

  • 4. Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
    Lotan Y
    Eur Urol; 2007 Aug; 52(2):453-4. PubMed ID: 17674436
    [No Abstract]   [Full Text] [Related]  

  • 5. Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?
    Khatami A; Pihl CG; Norrby K; Hugosson J; Damber JE
    Acta Oncol; 2005; 44(4):362-8. PubMed ID: 16120545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy.
    Gacci M; Serni S; Lapini A; Vittori G; Vignolini G; Nesi G; Carini M
    Prostate Cancer Prostatic Dis; 2008; 11(1):99-101. PubMed ID: 17923856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
    Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New horizons of radical prostatectomy in the treatment of localized prostatic cancer].
    Solsona Narbón E
    Actas Urol Esp; 1995 Mar; 19(3):175-9. PubMed ID: 8659272
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
    Stephenson AJ; Kattan MW; Eastham JA; Dotan ZA; Bianco FJ; Lilja H; Scardino PT
    J Clin Oncol; 2006 Aug; 24(24):3973-8. PubMed ID: 16921049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA; Koch MO; Lopez-Beltran A; Montironi R; Juliar BE; Cheng L
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PSA kinetics after total prostatectomy].
    Riedinger JM; Eche N; Fulla Y; Thuillier F
    Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.
    Simmons MN; Stephenson AJ; Klein EA
    Eur Urol; 2007 May; 51(5):1175-84. PubMed ID: 17240528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A; Murai M; Baba S; Ogawa O; Tsukamoto T; Niwakawa M; Tobisu K; Kinukawa N; Naito S
    BJU Int; 2006 Sep; 98(3):549-53. PubMed ID: 16925752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.
    Park S; Wians FH; Cadeddu JA
    Int J Urol; 2007 Mar; 14(3):251-3. PubMed ID: 17430267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomy.
    Hisasue S; Yanase M; Shindo T; Iwaki H; Fukuta F; Nishida S; Muranaka T; Miyamoto S; Tsukamoto T; Takatsuka K
    Jpn J Clin Oncol; 2008 Feb; 38(2):129-33. PubMed ID: 18281308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of detectable PSA levels after radical prostatectomy.
    Ahlering TE; Skarecky DW
    Prostate Cancer Prostatic Dis; 2005; 8(2):163-6. PubMed ID: 15711604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.